loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 202179 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Rising Pharmaceuticals Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 RISING (3)

    filter

    01 TABLET, ORALLY DISINTEGRATING;ORAL (3)

    filter

    01 DISCN (3)

    filter

    01 PREDNISOLONE SODIUM PHOSPHATE (3)

    filter

    01 No (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      PREDNISOLONE SODIUM PHOSPHATE

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET, ORALLY DIS...
      EQ 10MG BASE
      2013-04-10
      202179
      PREDNISOLONE SODIU...
      DISCN
      No
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        PREDNISOLONE SODIUM PHOSPHATE

        PDF Supplier PDF
        URL Supplier Web Content
        TABLET, ORALLY DIS...
        EQ 15MG BASE
        2013-04-10
        202179
        PREDNISOLONE SODIU...
        DISCN
        No
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          PREDNISOLONE SODIUM PHOSPHATE

          PDF Supplier PDF
          URL Supplier Web Content
          TABLET, ORALLY DIS...
          EQ 30MG BASE
          2013-04-10
          202179
          PREDNISOLONE SODIU...
          DISCN
          No
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for FDA Orange Book APPLICATION 202179

          Looking for FDA Orange Book APPLICATION 202179 3

          19

          Rising Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company.

          One of their notable products is PREDNISOLONE SODIUM PHOSPHATE, with a corresponding application number 202179.

          Regulatory Information DISCN

          With a dosage strength EQ 10MG BASE

          Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL

          Reference Listed Drug No

          Approved since 2013-04-10

          18

          Rising Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company.

          One of their notable products is PREDNISOLONE SODIUM PHOSPHATE, with a corresponding application number 202179.

          Regulatory Information DISCN

          With a dosage strength EQ 15MG BASE

          Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL

          Reference Listed Drug No

          Approved since 2013-04-10

          17

          Rising Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company.

          One of their notable products is PREDNISOLONE SODIUM PHOSPHATE, with a corresponding application number 202179.

          Regulatory Information DISCN

          With a dosage strength EQ 30MG BASE

          Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL

          Reference Listed Drug No

          Approved since 2013-04-10

          Post Enquiry
          POST ENQUIRY